Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010

Journal of Urban Health

Volumn 90, Issue 2, 2013, Pages 276-283

  Lutnick, Alexandra ^a   Cooper, Erin ^b   Dodson, Chaka ^b   Bluthenthal, Ricky ^c   Kral, Alex H ^a  

^a RTI INTERNATIONAL   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

California; IDU; Nonprescription syringe sales; Pharmacy; Policy; SB1159

Indexed keywords

ARTICLE; COMMERCIAL PHENOMENA; ECONOMICS; HUMAN; INFECTION CONTROL; LEGAL ASPECT; PHARMACY; PREVENTIVE HEALTH SERVICE; QUALITATIVE RESEARCH; SUBSTANCE ABUSE; SYRINGE; UNITED STATES;

COMMERCE; COMMUNICABLE DISEASE CONTROL; COMMUNITY PHARMACY SERVICES; HUMANS; LOS ANGELES; NEEDLE-EXCHANGE PROGRAMS; QUALITATIVE RESEARCH; SAN FRANCISCO; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 84876294434     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-012-9713-7     Document Type: Article

References (26)

1. Injection drug users and their sex/needle sharing partners. Sacramento: Office of AIDS, California Department of Public Health; September 2007.
2. Alter MJ, Margolis HS, Bell BP, et al. Recommendations for the prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 1998; 47(RR19): 1-36.
3. Rodgers AB, Jones S, Abdul-Quader A, et al. New attitudes and strategies: a comprehensive approach to preventing blood-borne infections among IDUs. Atlanta, GA: Centers for Disease Control and Prevention; 2000.
4. Gayle HD, O'Neill JF, Gust SW, Mata A. HIV Prevention bulletin: medical advice for persons who inject illicit drugs. Atlanta, GA: US Department of Health and Human Services; 1997.
5. Bluthenthal RN, Heinzerling KG, Anderson R, Flynn NM, Kral AH. Approval of syringe exchange programs in California: results from a local approach to HIV prevention. Am J Public Health. 2008; 98(2): 278-283.
6. Stopka TJ, Garfein RS, Ross A, Truax SR. Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health. 2007; 84(1): 116-125.
7. Garfein RS, Stopka TJ, Pavlinac PB, et al. Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now? J Urban Health. 2010; 87(4): 576-585.
8. Cleland CM, Deren S, Fuller CM, et al. Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Health Educ Behav. 2007; 34(2): 390-403.
9. Singer M, Baer HA, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Rep. 1998; 113(Suppl 1): 81-89.
10. Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97(1): 117-124.
11. Pouget ER, Deren S, Fuller CM, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005; 39(4): 471-477.
12. Rich JD, Hogan JW, Wolf F, et al. Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug Alcohol Depend. 2007; 89(2-3): 292-297.
13. Friedman SR, Perlis T, Des Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health. 2001; 91(5): 791-793.
14. Deren S, Cleland CM, Fuller C, Kang SY, Des Jarlais DC, Vlahov D. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings. AIDS Behav. 2006; 10(6): 717-721.
15. Deibert RJ, Goldbaum G, Parker TR, et al. Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003. Am J Public Health. 2006; 96(8): 1347-1353.
16. Farley TA, Niccolai LM, Billeter M, Kissinger PJ, Grace M. Attitudes and practices of pharmacy managers regarding needle sales to injection drug users. J Am Pharm Assoc (Wash). 1999; 39(1): 23-26.
17. Blumenthal W, Springer K, Jones S, Stark C. Pharmacy student knowledge, attitudes and beliefs about selling syringes to injection drug users. J Am Pharm Assoc. 2002; 42(6): S34-S39.
18. Taussig J, Junge B, Burris S, Jones TS, Sterk CE. Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S40-S45.
19. Kral AH, Garfein RS. Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California. J Urban Health. 2010; 87(4): 531-533.
20. Cooper EN, Dodson C, Stopka TJ, Riley ED, Garfein RS, Bluthenthal RN. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007. J Urban Health. 2010; 87(4): 543-552.
21. Rose VJ, Raymond HF. Evaluation of nonprescription syringe sales in San Francisco. J Am Pharm Assoc. 2010; 50(5): 595-599.
22. Compton W, Horton J, Cottler L, et al. A multistate trial of pharmacy syringe purchase. J Urban Health. 2004; 81(4): 661-670.
23. Finkelstein R, Tiger R, Greenwald R, Mukherjee R. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002). J Am Pharm Assoc. 2002; 42(Supplement 1): S83-S87.
24. Trubatch BN, Fisher DG, Cagle HH, Fenaughty AM, Johnson ME. Nonprescription pharmacy sales of needles and syringes. Am J Public Health. 2000; 90(10): 1639-1640.
25. Koester SK, Bush TW, Lewis BA. Limited access to syringes for injection drug users in pharmacies in Denver, Colorado. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S88-S91.
26. Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. J Urban Health. 2010; 87(4): 534-542.